| (GBp) | Jun 2025 | Y/Y change |
|---|---|---|
| Revenue | 4.64M | 283.74% |
| Operating expense | — | — |
| Net income | 0.00 | -100.00% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, SBTX.L returned -34.5% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -39.7% |
| 1 year | -34.5% |
| 5 years | -84.7% |
| All-time high | GBX 71.00 (Oct 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what £1,000 in SBTX.L would be worth today ›No. SkinBioTherapeutics plc has not paid a dividend in the past 12 months.
SkinBioTherapeutics plc is part of the Healthcare sector.
SkinBioTherapeutics plc has a market cap of 24.62M GBp, based on the latest quote.
